Galderma Group AG
Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 26
- Registration Number
- NCT00436527
- Locations
- 🇺🇸
Colorado Springs Research Center, Colorado Springs, Colorado, United States
Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 2488
- Registration Number
- NCT00437216
- Locations
- 🇺🇸
DHC Dimensional HealthCare, Inc. (Clinical Research Organization), Cedar Knolls, New Jersey, United States
A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 78
- Registration Number
- NCT00436540
- Locations
- 🇺🇸
Solano Clinical Research, Vallejo, California, United States
🇺🇸Central Dermatology, PC, Saint Louis, Missouri, United States
Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 122
- Registration Number
- NCT00437255
- Locations
- 🇺🇸
Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
🇺🇸J & S Studies, Inc., Bryan, Texas, United States
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
- Conditions
- Acne
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 61
- Registration Number
- NCT00437151
- Locations
- 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Benzoyl Peroxide Gel 2.5%Drug: Gel Vehicle
- First Posted Date
- 2007-01-15
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 1668
- Registration Number
- NCT00422240
- Locations
- 🇺🇸
Miller MD, San Antonio, Texas, United States
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2007-01-15
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 1670
- Registration Number
- NCT00421993
- Locations
- 🇺🇸
Medical Affliated Research Center, Huntsville, Alabama, United States
🇺🇸Dermatology Research of Arkansas, Little Rock, Arkansas, United States
🇺🇸Associates in research, Inc., Fresno, California, United States
A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 25
- Registration Number
- NCT00419666
- Locations
- 🇺🇸
Dermatology Research of Arkansas, Little Rock, Arkansas, United States
🇺🇸Children's Hospital, Department of Pediatric and Adolescent Dermatology, San Diego, California, United States
🇺🇸Dermatology Center For Children & Young Adults, Eagan, Minnesota, United States
Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis
- Conditions
- Scalp Psoriasis
- Interventions
- First Posted Date
- 2006-11-17
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 288
- Registration Number
- NCT00400725
- Locations
- 🇨🇦
centre de Recherche Dermatologique du Québec, Quebec, Canada
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
- Conditions
- Actinic Keratosis
- First Posted Date
- 2006-03-24
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 80
- Registration Number
- NCT00306800
- Locations
- 🇺🇸
Spencer Dermatology and Skin Surgery, Saint Petersburg, Florida, United States
🇺🇸Laser and Skin Surgery Center, New York, New York, United States
🇺🇸Dermatology Associates of Rochester, Rochester, New York, United States